• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射地塞米松植入物治疗的糖尿病性黄斑水肿眼的预后影像生物标志物

Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.

作者信息

Costanzo Eliana, Giannini Daniela, De Geronimo Daniele, Fragiotta Serena, Varano Monica, Parravano Mariacristina

机构信息

IRCCS-Fondazione Bietti, Rome, Italy.

Ophthalmology Unit, Department NESMOS, Sant' Andrea Hospital, University of Rome "La Sapienza", Rome, Italy.

出版信息

J Clin Med. 2023 Feb 6;12(4):1303. doi: 10.3390/jcm12041303.

DOI:10.3390/jcm12041303
PMID:36835839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9968175/
Abstract

BACKGROUND

The aim was to evaluate predictive value of baseline optical coherence tomography (OCT) and OCT angiography (OCTA) parameters in diabetic macular edema (DME) treated with dexamethasone implant (DEXi).

METHODS

OCT and OCTA parameters were collected: central macular thickness (CMT), vitreomacular abnormalities (VMIAs), intraretinal and subretinal fluid (mixed DME pattern), hyper-reflective foci (HRF), microaneurysms (MAs) reflectivity, ellipsoid zone disruption, suspended scattering particles in motion (SSPiM), perfusion density (PD), vessel length density, and foveal avascular zone. Responders' (RES) and non-responders' (n-RES) eyes were classified considering morphological (CMT reduction ≥ 10%) and functional (BCVA change ≥ 5 ETDRS letters) changes after DEXi. Binary logistic regression OCT, OCTA, and OCT/OCTA-based models were developed.

RESULTS

Thirty-four DME eyes were enrolled (18 treatment-naïve). OCT-based model combining DME mixed pattern + MAs + HRF and OCTA-based model combining SSPiM and PD showed the best performance to correctly classify the morphological RES eyes. In the treatment-naïve eyes, VMIAs were included with a perfect fit for n-RES eyes.

CONCLUSION

The presence of DME mixed pattern, a high number of parafoveal HRF, hyper-reflective MAs, SSPiM in the outer nuclear layers, and high PD represent baseline predictive biomarkers for DEXi treatment responsiveness. The application of these models to treatment-naïve patients allowed a good identification of n-RES eyes.

摘要

背景

目的是评估基线光学相干断层扫描(OCT)和OCT血管造影(OCTA)参数在接受地塞米松植入物(DEXi)治疗的糖尿病性黄斑水肿(DME)中的预测价值。

方法

收集OCT和OCTA参数:中心黄斑厚度(CMT)、玻璃体黄斑异常(VMIAs)、视网膜内和视网膜下液(混合性DME模式)、高反射灶(HRF)、微动脉瘤(MAs)反射率、椭圆体带破坏、运动中的悬浮散射颗粒(SSPiM)、灌注密度(PD)、血管长度密度和黄斑无血管区。根据DEXi治疗后形态学(CMT降低≥10%)和功能(最佳矫正视力变化≥5个ETDRS字母)变化,对有反应者(RES)和无反应者(n-RES)的眼睛进行分类。建立基于OCT、OCTA和OCT/OCTA的二元逻辑回归模型。

结果

纳入34只DME眼(18只初治眼)。基于OCT的模型(结合DME混合模式+MAs+HRF)和基于OCTA的模型(结合SSPiM和PD)在正确分类形态学有反应的眼睛方面表现最佳。在初治眼中,VMIAs纳入对无反应者眼睛的拟合效果极佳。

结论

DME混合模式、大量黄斑旁HRF、高反射性MAs、外核层中的SSPiM以及高PD的存在代表了DEXi治疗反应性的基线预测生物标志物。将这些模型应用于初治患者可很好地识别无反应者的眼睛。

相似文献

1
Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.玻璃体内注射地塞米松植入物治疗的糖尿病性黄斑水肿眼的预后影像生物标志物
J Clin Med. 2023 Feb 6;12(4):1303. doi: 10.3390/jcm12041303.
2
OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.OCT 生物标志物作为经地塞米松植入物治疗的糖尿病性黄斑水肿的功能预后预测指标。
Ophthalmology. 2018 Feb;125(2):267-275. doi: 10.1016/j.ophtha.2017.08.031. Epub 2017 Sep 19.
3
SUSPENDED SCATTERING PARTICLES IN MOTION MAY INFLUENCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VESSEL DENSITY METRICS IN EYES WITH DIABETIC MACULAR EDEMA.运动中悬浮的散射颗粒可能会影响糖尿病黄斑水肿眼中光学相干断层扫描血管造影的血管密度测量值。
Retina. 2021 Jun 1;41(6):1259-1264. doi: 10.1097/IAE.0000000000003016.
4
Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.糖尿病性黄斑水肿伴神经视网膜脱离:抗 VEGF 和皮质类固醇治疗反应的 OCT 和 OCT 血管造影生物标志物。
Acta Diabetol. 2020 Mar;57(3):287-296. doi: 10.1007/s00592-019-01424-4. Epub 2019 Sep 21.
5
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.基线 SD-OCT 特征可预测糖尿病黄斑水肿模式,并可预测接受玻璃体内注射地塞米松植入物治疗的患者的形态学特征和复发时间。
Acta Diabetol. 2020 Jul;57(7):867-874. doi: 10.1007/s00592-020-01504-w. Epub 2020 Feb 29.
6
Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers.阈下微脉冲激光治疗糖尿病性黄斑水肿:光学相干断层扫描/光学相干断层扫描血管造影生物标志物的1年改善情况
Transl Vis Sci Technol. 2020 Sep 30;9(10):31. doi: 10.1167/tvst.9.10.31. eCollection 2020 Sep.
7
Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants.光学相干断层扫描生物标志物在预测地塞米松植入术后糖尿病性黄斑水肿治疗效果中的应用
Front Med (Lausanne). 2022 Jun 9;9:852022. doi: 10.3389/fmed.2022.852022. eCollection 2022.
8
Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.高反射灶和视网膜下液是评估糖尿病性黄斑水肿抗VEGF治疗效果的潜在影像学生物标志物。
Front Physiol. 2021 Dec 23;12:791442. doi: 10.3389/fphys.2021.791442. eCollection 2021.
9
Dilated retinal large vessels and capillaries associated with diabetic macular edema and photoreceptor loss respectively.视网膜大血管和毛细血管扩张分别与糖尿病性黄斑水肿和光感受器损失有关。
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1831-1837. doi: 10.1007/s00417-020-05039-2. Epub 2021 Jan 8.
10
Optical coherence tomography angiography analysis of microvascular abnormalities and vessel density in treatment-naïve eyes with diabetic macular edema.未经治疗的糖尿病黄斑水肿患者的微血管异常和血管密度的光相干断层扫描血管造影分析。
BMC Ophthalmol. 2022 Nov 3;22(1):418. doi: 10.1186/s12886-022-02632-3.

引用本文的文献

1
Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)-Refractory to Medical Therapy.玻璃体腔注射地塞米松植入治疗人工晶状体眼玻璃体切除术后药物治疗无效的黄斑囊样水肿(CME)的12个月结局及光学相干断层扫描(OCT)生物标志物
Diagnostics (Basel). 2025 Jan 10;15(2):147. doi: 10.3390/diagnostics15020147.
2
Study of Imaging Biomarkers as a Prognostic Factor and Guide in the Management of Diabetic Macular Oedema.成像生物标志物作为糖尿病性黄斑水肿管理中的预后因素和指导的研究。
Cureus. 2024 Nov 15;16(11):e73765. doi: 10.7759/cureus.73765. eCollection 2024 Nov.
3
OCT angiography 2023 update: focus on diabetic retinopathy.OCT 血管造影 2023 更新:关注糖尿病视网膜病变。
Acta Diabetol. 2024 May;61(5):533-541. doi: 10.1007/s00592-024-02238-9. Epub 2024 Feb 20.
4
Predictive Factors of Visual Outcome in Treatment-Naïve Diabetic Macular Edema: Preliminary Results from the Clinical Study "FOVEA".初治糖尿病性黄斑水肿视力预后的预测因素:临床研究“FOVEA”的初步结果
J Clin Med. 2023 Jun 6;12(12):3870. doi: 10.3390/jcm12123870.

本文引用的文献

1
Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods.持续性糖尿病性黄斑水肿:定义、发生率、生物标志物和治疗方法。
Surv Ophthalmol. 2023 Mar-Apr;68(2):147-174. doi: 10.1016/j.survophthal.2022.11.008. Epub 2022 Nov 24.
2
Impact of Intravitreal Anti-VEGF Therapy on Microperimetry of the Retinal Nonperfusion Areas of Patients with Proliferative Diabetic Retinopathy.玻璃体内抗血管内皮生长因子治疗对增殖性糖尿病视网膜病变患者视网膜无灌注区微视野检查的影响
Ophthalmol Ther. 2022 Dec;11(6):2117-2128. doi: 10.1007/s40123-022-00568-x. Epub 2022 Sep 17.
3
Deep Capillary Geometric Perfusion Deficits on OCT Angiography Detect Clinically Referable Eyes with Diabetic Retinopathy.OCT 血管造影上的深层毛细血管几何灌注不足可检测出有临床意义的糖尿病视网膜病变眼。
Ophthalmol Retina. 2022 Dec;6(12):1194-1205. doi: 10.1016/j.oret.2022.05.028. Epub 2022 Jun 2.
4
Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity.广角扫频源光学相干断层扫描血管造影术测量的无灌注区及其他血管指标作为糖尿病视网膜病变严重程度的生物标志物
Ophthalmol Sci. 2022 Jun;2(2). doi: 10.1016/j.xops.2022.100144. Epub 2022 Mar 18.
5
Hyperreflective Dots on OCT as a Predictor of Treatment Outcome in Diabetic Macular Edema: A Systematic Review.OCT 上的高反射点预测糖尿病性黄斑水肿的治疗效果:系统评价。
Ophthalmol Retina. 2022 Sep;6(9):814-827. doi: 10.1016/j.oret.2022.03.020. Epub 2022 Mar 30.
6
Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant.光学相干断层扫描和成像生物标志物作为治疗糖尿病黄斑水肿的地塞米松植入物的疗效预测指标。
Sci Rep. 2022 Mar 9;12(1):3872. doi: 10.1038/s41598-022-07604-7.
7
Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications.高反射灶作为视网膜疾病光学相干断层扫描生物标志物的意义:特征与临床意义
J Ophthalmol. 2021 Dec 17;2021:6096017. doi: 10.1155/2021/6096017. eCollection 2021.
8
Differentiating features of OCT angiography in diabetic macular edema.OCT 血管造影在糖尿病性黄斑水肿中的特征表现。
Sci Rep. 2021 Dec 3;11(1):23398. doi: 10.1038/s41598-021-02859-y.
9
Differences in cysts characteristics and related influence on the anatomical response after dexamethasone implant in diabetic macular oedema.糖尿病性黄斑水肿中,囊肿特征的差异及其对地塞米松植入后解剖反应的相关影响。
Eye (Lond). 2022 Jun;36(6):1329-1331. doi: 10.1038/s41433-021-01857-8. Epub 2021 Nov 24.
10
Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization.1 型黄斑新生血管 1 年活动性的影像学标志物。
Transl Vis Sci Technol. 2021 May 3;10(6):18. doi: 10.1167/tvst.10.6.18.